Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Valerie Odegard
AddedMar 31, 2024
UpdatedMay 31, 2026
Valerie Odegard

Valerie Odegard

Board Member, iTeos Therapeutics

CrunchbaseLinkedIn

Valerie Odegard's Career

iTeos Therapeutics
iTeos Therapeutics

Watertown, MA, US

Board Member· Board
Abata Therapeutics
Abata Therapeutics

Cambridge, MA, US

Board Member· Board
Odyssey Therapeutics
Odyssey Therapeutics

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Valerie Odegard's Career

iTeos Therapeutics
iTeos Therapeutics
Public$242.7M1252011Watertown, MA, US
Board Member· Board

Leadership at iTeos Therapeutics

Michel DetheuxMichel DetheuxFounder
David HallalDavid HallalBoard Member
Ann D. RhoadsAnn D. RhoadsBoard Member
Tim Van HauwermeirenTim Van HauwermeirenBoard Member
Chris BuyseChris BuyseBoard Member
Abata Therapeutics
Abata Therapeutics
Series A$95M572021Cambridge, MA, US
Board Member· Board

Leadership at Abata Therapeutics

Abbie CelnikerAbbie CelnikerBoard Member
Samantha SingerSamantha SingerCEO
Lorence KimLorence KimBoard Member
Richard RansohoffRichard RansohoffFounder
Odyssey Therapeutics
Odyssey Therapeutics
Series C$487M1752021Cambridge, MA, US
Board Member· Board

Leadership at Odyssey Therapeutics

Gary GlickGary GlickBoard Member
Jill CarrollJill CarrollBoard Member
Jeffrey LeidenJeffrey LeidenBoard Member
Carl L. GordonCarl L. GordonBoard Member
David L. PomplianoDavid L. PomplianoCo-Founder
Charles Baum, MD, PhDCharles Baum, MD, PhDBoard Member

Similar to Odyssey Therapeutics

Odyssey TheraOdyssey TheraSan Ramon, CA, USCancer Therapiesest. 2000Odyssey TheraSan Ramon, CA, US · est. 2000

Odyssey Thera, Inc.: A US-based biopharmaceutical company specializing in cancer therapies.

Public · $6.3M30
Nested TherapeuticsNested TherapeuticsCambridge, MA, USTherapeuticsest. 2021Nested TherapeuticsCambridge, MA, US · est. 2021

Nested Therapeutics: A biotech innovator designing impactful therapeutics through creative service.

Series A · $125M50
Synnovation TherapeuticsSynnovation TherapeuticsWilmington, DE, USOncology Therapiesest. 2021Synnovation TherapeuticsWilmington, DE, US · est. 2021

Synnovation Therapeutics: Precision oncology firm specializing in small molecule therapies for cancer.

Series A · $139M18
Scorpion TherapeuticsScorpion TherapeuticsBoston, MA, USCancer Treatmentest. 2020Scorpion TherapeuticsBoston, MA, US · est. 2020

Scorpion Therapeutics, a Boston-based medical organization, innovates in precision oncology for enhanced cancer treatment.

Series B · $270M130

Valerie Odegard's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Valerie Odegard

Rishi GuptaRishi GuptaBoard Member · Aer TherapeuticsQ Khuong ChauQ Khuong ChauBoard Member · NextCureMichael B ShefferyMichael B ShefferyCo-Founder · OrbiMed AdvisorsSam IsalySam IsalyFounder · Exome Asset ManagementPat GradyPat GradyBoard Member · Okta